Jim Simons's position in Xeris Biopharma Holdings is currently worth $10.5 Million. That's 0.02% of their equity portfolio (897th largest holding). The investor owns 1.36% of the outstanding Xeris Biopharma Holdings stock. The first Xeris Biopharma Holdings trade was made in Q2 2019. Since then Jim Simons bought shares twelve more times and sold shares on nine occasions. The stake costed the investor $6.9 Million, netting the investor a gain of 52% so far.